pamidronate and prednisone

pamidronate has been researched along with prednisone in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (15.38)18.2507
2000's5 (38.46)29.6817
2010's5 (38.46)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Frickhofen, N; Friedrich, JM; Hoffmeister, A; Mattfeldt, T; Merkle, E; Prümmer, O; Weber, CK1
Dunkley, S; Gibson, J; Iland, H; Joshua, D; Li, C1
Calvert, PC; Kerrison, JB; Miller, NR; Subramanian, PS1
Angelopoulou, MK; Dimopoulou, MN; Gribabis, DA; Kokoris, SI; Kyrtsonis, MC; Pangalis, GA; Siakantaris, MP; Vassilakopoulos, TP1
Berrut, G; Foussard, C; Frein, D; Josselin, N; Lavigne, C; Moles, MP; Sivova, N1
Basok, AB; Haviv, YS; Rogachev, B; Vorobiov, M1
Bo, Z; Gangfeng, G; Jian, W; Jian, Y; Ke, H; Maoxia, L; Xiaojing, L; Xiaolan, L; Yan, L; Yang, F; Zhao, C1

Reviews

2 review(s) available for pamidronate and prednisone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Pharmacotherapies for Central Post-Stroke Pain: A Systematic Review and Network Meta-Analysis.
    Oxidative medicine and cellular longevity, 2022, Volume: 2022

    Topics: Anticonvulsants; Etanercept; Humans; Lamotrigine; Levetiracetam; Network Meta-Analysis; Pain; Pamidronate; Prednisone; Pregabalin

2022

Other Studies

11 other study(ies) available for pamidronate and prednisone

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Reversible metastatic pulmonary calcification in a patient with multiple myeloma.
    Annals of hematology, 1996, Volume: 72, Issue:5

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Calcinosis; Diphosphonates; Female; Humans; Lung Diseases; Melphalan; Middle Aged; Multiple Myeloma; Pamidronate; Prednisone; Tomography, X-Ray Computed

1996
Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
    Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Lineage; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Clone Cells; Combined Modality Therapy; Diphosphonates; Embryonal Carcinoma Stem Cells; Female; Gene Rearrangement, B-Lymphocyte, Light Chain; Humans; Idarubicin; Immunoglobulin kappa-Chains; Leukemia, Promyelocytic, Acute; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Proteins; Neoplasms, Multiple Primary; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Osteolysis; Pamidronate; Prednisone; Remission Induction; Translocation, Genetic; Tretinoin

1999
Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2003, Volume: 121, Issue:9

    Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Humans; Male; Middle Aged; Orbital Pseudotumor; Pamidronate; Prednisone; Prostatic Neoplasms

2003
Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
    European journal of haematology, 2004, Volume: 72, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers, Tumor; Bone Resorption; Cyclophosphamide; Dexamethasone; Diphosphonates; Doxorubicin; Female; Fibroblast Growth Factor 2; Follow-Up Studies; Glycoproteins; Humans; Life Tables; Male; Melphalan; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Neoplasm Proteins; Neoplasm Staging; Neovascularization, Pathologic; Osteoprotegerin; Pamidronate; Prednisone; Prognosis; Proteoglycans; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Survival Analysis; Syndecan-1; Syndecans; Vincristine

2004
[Hypercalcaemia and malignant lymphoma. One case report].
    La Revue de medecine interne, 2007, Volume: 28, Issue:10

    Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcitriol; Diphosphonates; Glucocorticoids; Humans; Hypercalcemia; Lymphoma, Non-Hodgkin; Male; Palliative Care; Pamidronate; Prednisone; Testicular Neoplasms

2007
Treatment of extreme hypercalcaemia: the role of haemodialysis.
    BMJ case reports, 2018, Jun-04, Volume: 2018

    Topics: Adenoma; Aged; Bone Density Conservation Agents; Calcitonin; Dexamethasone; Diphosphonates; Fluid Therapy; Glucocorticoids; Humans; Hypercalcemia; Male; Pamidronate; Parathyroid Neoplasms; Prednisone; Renal Dialysis; Severity of Illness Index; Tomography, X-Ray Computed

2018